Downregulation of lncRNA LINC01465 predicts ovarian endometriosis and its prognosis

article OA: closed CC0 ⤵ 2 in-corpus citations
AI-generated summary by claude@2026-06+body, 2026-06-12

Lower expression of lncRNA LINC01465 in ectopic endometrial tissues indicates its role in ovarian endometriosis pathogenesis and potential diagnostic value.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text

This study examined whether lncRNA LINC01465 is involved in ovarian endometriosis and whether it could serve as a diagnostic and prognostic biomarker. Using RT-qPCR, the authors measured LINC01465 expression in ectopic and paired eutopic endometrial tissues from 80 endometriosis patients and also assessed serum LINC01465 levels from all 160 participants, followed by 3-year follow-up after treatment to monitor recurrence. LINC01465 expression was significantly lower in ectopic tissues than in paired eutopic tissues for most patients, and serum LINC01465 increased after treatment; patients who experienced recurrence had significantly lower serum levels than those who did not, with no correlation observed between serum levels and age or lifestyle. The paper does not clearly state a major experimental limitation beyond its sample size, and it does not provide external validation cohorts. This paper is centrally about endometriosis — specifically, downregulation of lncRNA LINC01465 as a diagnostic and prognostic marker in ovarian endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The well-known impact of ovarian endometriosis on female quality of life and the established role of lncRNA LINC01465 in ovarian cancer pathogenesis have been extensively documented; however, the relationship between LINC01465 and ovarian endometriosis is still not clear. This study seeks to explore the potential involvement of LINC01465 in the disease. The study analyzed a sample of 80 endometriosis patients and 80 healthy women. The expression of LINC01465 was measured in ectopic and eutopic endometrial tissues through RT-qPCR. The diagnostic potential of serum LINC01465 levels was evaluated using ROC curve analysis, and the patients were followed up for 3 years after treatment to monitor recurrence. The results revealed that the expression of LINC01465 was significantly lower in ectopic endometrial tissues in comparison to paired eutopic tissues for most of the patients. No correlation was found between the patient's age or lifestyle and serum LINC01465 levels. After treatment, the serum LINC01465 level increased, and patients who experienced recurrence had significantly lower levels compared to those who did not. In conclusion, the study findings suggest that the downregulation of LINC01465 plays a role in the pathogenesis of ovarian endometriosis and may serve as a diagnostic and prognostic biomarker for the disease.
Full text 6,776 characters · extracted from oa-doi-fallback · click to expand
Summary The well-known impact of ovarian endometriosis on female quality of life and the established role of lncRNA LINC01465 in ovarian cancer pathogenesis have been extensively documented; however, the relationship between LINC01465 and ovarian endometriosis is still not clear. This study seeks to explore the potential involvement of LINC01465 in the disease. The study analyzed a sample of 80 endometriosis patients and 80 healthy women. The expression of LINC01465 was measured in ectopic and eutopic endometrial tissues through RT-qPCR. The diagnostic potential of serum LINC01465 levels was evaluated using ROC curve analysis, and the patients were followed up for 3 years after treatment to monitor recurrence. The results revealed that the expression of LINC01465 was significantly lower in ectopic endometrial tissues in comparison to paired eutopic tissues for most of the patients. No correlation was found between the patient’s age or lifestyle and serum LINC01465 levels. After treatment, the serum LINC01465 level increased, and patients who experienced recurrence had significantly lower levels compared to those who did not. In conclusion, the study findings suggest that the downregulation of LINC01465 plays a role in the pathogenesis of ovarian endometriosis and may serve as a diagnostic and prognostic biomarker for the disease. Similar content being viewed by others References Králíčková M, Laganà AS, Ghezzi F, Vetvicka V. Endometriosis and risk of ovarian cancer: what do we know? Arch Gynecol Obstet. 2020;301:1–10. Mo X, Zeng Y. The relationship between ovarian endometriosis and clinical pregnancy and abortion rate based on logistic regression model. Saudi J Biol Sci. 2020;27:561–6. Streuli I, Gaitzsch H, Wenger JM, Petignat P. Endometriosis after menopause: physiopathology and management of an uncommon condition. Climacteric. 2017;20:138–43. Falcone T, Flyckt R. Clinical Management of Endometriosis. Obstet Gynecol. 2018;131:557–71. van Barneveld E, Manders J, van Osch FHM, van Poll M, Visser L, van Hanegem N, Lim AC, Bongers MY, Leue C. Depression, Anxiety, and Correlating Factors in Endometriosis: A Systematic Review and Meta-Analysis. J Women’s Heal. 2021;31:219–30. Broi MGD, Ferriani RA, Navarro PA. Ethiopathogenic mechanisms of endometriosis-related infertility. Jbra Assist Reprod. 2019;23:273–80. Brilhante AV, Augusto KL, Portela MC, Sucupira LC, Oliveira LA, Pouchaim AJ, Nóbrega LR, Magalhães TF, Sobreira LR. Endometriosis and Ovarian Cancer: an Integrative Review (Endometriosis and Ovarian Cancer). Asian Pac J Cancer Prev. 2017;18:11–6. Bozdag G. Recurrence of endometriosis: risk factors, mechanisms and biomarkers. Womens Health. 2015;11:693–9. Ceccaroni M, Bounous VE, Clarizia R, Mautone D, Mabrouk M. Recurrent endometriosis: a battle against an unknown enemy. Eur J Contracept Reproductive Health Care. 2019;24:464–74. Maggiore ULR, Ferrero S, Mangili G, Bergamini A, Inversetti A, Giorgione V, Vigano P, Candiani M. A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. Hum Reprod Update. 2016;22:70–103. Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet. 2021;397:839–52. Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA, Singh SS, Taylor HS. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220:354.e351–354.e312. Bai J, Wang B, Wang T, Ren W. Identification of functional lncRNas associated with ovarian endometriosis based on a ceRNA network. Front Genet. 2021;12:534054. https://doi.org/10.3389/fgene.2021.534054 Cui D, Ma J, Liu Y, Lin K, Jiang X, Qu Y, Lin J, Xu K. Analysis of long non-coding RNA expression profiles using RNA sequencing in ovarian endometriosis. Gene. 2018;673:140–8. Lin K, Zhan H, Ma J, Xu K, Wu R, Zhou C, Lin J. Silencing of SRA1 regulates ER expression and attenuates the growth of stromal cells in ovarian endometriosis. Reprod Sci. 2017;24:836–43. Malgundkar SH, Hassan NA, Al Badi H, Gupta I, Burney IA, Al Hashami Z, Al Barwani H, Al Riyami H, Al Kalbani M, Lakhtakia R, et al. Identification and validation of a novel long non-coding RNA (LINC01465) in ovarian cancer. Human Cell. 2022;36:762–74. Gabriel M, Fey V, Heinosalo T, Adhikari P, Rytkonen K, Komulainen T, Huhtinen K, Laajala TD, Siitari H, Virkki A, et al. A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions. Sci Data. 2020;7(1):284. [No authors listed]. Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril. 2000;74:641–653. Perkins A. The “silent” pain of endometriosis. Nurs Made Incred Easy. 2019;17:26–33. Koga K, Takamura M, Fujii T, Osuga Y. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril. 2015;104:793–801. Funding We thank the financial support from the Innovative R&D project of Hunan Provincial Development and Reform Commission (No. 37). Author information Authors and Affiliations Contributions YS conducted this study and wrote this manuscript. RH, XH, SW, SC, GL, MO analyzed and interpreted the patient data. HG designed the study. All authors read and approved the final manuscript. Corresponding author Ethics declarations Conflict of interest Y. Song, R. Huang, X. Hu, S. Wu, S. Chen, G. Liu, M. Ou and H. Guo declare that they have no competing interests. Ethical standards All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Approval was obtained from the Ethics Committee of Changsha Maternal and Child Health Care Hospital. Written informed consent was obtained from all individual patients included in the study. Additional information Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Availability of data and material The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Rights and permissions About this article Cite this article Song, Y., Huang, R., Hu, X. et al. Downregulation of lncRNA LINC01465 predicts ovarian endometriosis and its prognosis. Wien Klin Wochenschr 136, 163–168 (2024). https://doi.org/10.1007/s00508-023-02219-y Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00508-023-02219-y

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms RNA, Long Noncoding

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (20)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-13T17:20:28.795615+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-06-13T17:19:22.563532+00:00
License: CC0 · commercial use OK